HURA

TUHURA BIOSCIENCES INC

HURA·898920103·US·Common Stock·Healthcare - Biotechnology-13D/G

HURA (TUHURA BIOSCIENCES INC) is held by 55 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($4.4M), VANGUARD CAPITAL MANAGEMENT LLC ($3.7M), GEODE CAPITAL MANAGEMENT, LLC ($1.8M). Net institutional sentiment: Bullish. In Q1 2026, 1 member of Congress and 42 funds bought HURA.

55
Holders
(6 Elite)
$15.7M
Total Value
84% (50)
Consensus
42 buying - 8 selling
13F: Insider & Congress:
HURA

Smart Money Verdict

View all
Held by 55 funds
6 elite

Who's Trading

ActivistHIHighbridge Capital Management, LLC9.1%Feb 17, 2026
ActivistThe Vanguard GroupThe Vanguard Group4.4%Oct 31, 2025
ActivistKBKP Biotech Group LLC0.9%Aug 14, 2025
ActivistCPCA Patel F&F Investments, LLC0.9%Aug 14, 2025
CongressLaurel LeeLaurel LeeBuy $50,001 - $100,000Jul 13, 2025
CongressLaurel LeeLaurel LeeBuy $1,001 - $15,000Nov 25, 2024
CongressLaurel LeeLaurel LeeSale $100,001 - $250,000Oct 18, 2024
CongressLaurel LeeLaurel LeeBuy $100,001 - $250,000May 6, 2024

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
2.5M(+56.4%)$4.4M0.0%-7.26%
38
New
2.1M$3.7M0.0%+36.45%
37
Increased
986,922(+49.0%)$1.8M0.0%-15.75%
35
Increased
607,168(+3580.3%)$1.1M0.0%+34.29%
41
Increased
512,913(+77.4%)$918,1140.0%+4.55%
26
Increased
298,187(+55.6%)$533,7540.0%-8.79%
34
New
287,133$513,9680.0%+36.45%
33
New
253,641$454,0170.0%+36.45%
37
Increased
211,568(+0.6%)$378,7080.0%-0.51%
24
New
140,244$251,0370.0%+36.45%
32
Increased
98,937(+20.8%)$177,0970.0%-10.76%
18
New
81,316$145,5560.0%+36.45%
31
Increased
78,142(+24.0%)$139,8740.0%+72.16%
18
Decreased
71,960(-9.8%)$128,8080.0%+71.77%
0
Increased
70,246(+79.7%)$125,7400.0%+90.47%
23
Increased
62,066(+120.6%)$111,0980.0%-5.27%
24
New
37,736$67,5470.0%+36.45%
29
Unchanged
33,575$60,0990.0%-4.73%
0
New
30,894$55,3010.0%+36.45%
32
New
30,847$55,2160.0%+36.45%
32

Showing 1-20 of 56

1 / 3
HURAHURATUHURA BIOSCIENCES INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used